Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies

Drug resistance is the main obstacle to achieving a cure in many cancer patients. Reactive oxygen species (ROS) are master regulators of cancer development that act through complex mechanisms. Remarkably, ROS levels and antioxidant content are typically higher in drug-resistant cancer cells than in...

Full description

Bibliographic Details
Main Authors: Xiaoting Zhou, Biao An, Yi Lin, Yanghong Ni, Xia Zhao, Xiao Liang
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Biomedicine & Pharmacotherapy
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0753332223008260
_version_ 1797744116861239296
author Xiaoting Zhou
Biao An
Yi Lin
Yanghong Ni
Xia Zhao
Xiao Liang
author_facet Xiaoting Zhou
Biao An
Yi Lin
Yanghong Ni
Xia Zhao
Xiao Liang
author_sort Xiaoting Zhou
collection DOAJ
description Drug resistance is the main obstacle to achieving a cure in many cancer patients. Reactive oxygen species (ROS) are master regulators of cancer development that act through complex mechanisms. Remarkably, ROS levels and antioxidant content are typically higher in drug-resistant cancer cells than in non-resistant and normal cells, and have been shown to play a central role in modulating drug resistance. Therefore, determining the underlying functions of ROS in the modulation of drug resistance will contribute to develop therapies that sensitize cancer resistant cells by leveraging ROS modulation. In this review, we summarize the notable literature on the sources and regulation of ROS production and highlight the complex roles of ROS in cancer chemoresistance, encompassing transcription factor–mediated chemoresistance, maintenance of cancer stem cells, and their impact on the tumor microenvironment. We also discuss the potential of ROS-targeted therapies in overcoming tumor therapeutic resistance.
first_indexed 2024-03-12T15:05:07Z
format Article
id doaj.art-2fb92838bb414d12bc491cb99a967f1c
institution Directory Open Access Journal
issn 0753-3322
language English
last_indexed 2024-03-12T15:05:07Z
publishDate 2023-09-01
publisher Elsevier
record_format Article
series Biomedicine & Pharmacotherapy
spelling doaj.art-2fb92838bb414d12bc491cb99a967f1c2023-08-13T04:52:22ZengElsevierBiomedicine & Pharmacotherapy0753-33222023-09-01165115036Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategiesXiaoting Zhou0Biao An1Yi Lin2Yanghong Ni3Xia Zhao4Xiao Liang5Department of Gynecology and Obstetrics, Development and Related Disease of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, Chengdu 610041, PR ChinaDepartment of Gynecology and Obstetrics, Development and Related Disease of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, Chengdu 610041, PR ChinaDepartment of Gynecology and Obstetrics, Development and Related Disease of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, Chengdu 610041, PR ChinaDepartment of Gynecology and Obstetrics, Development and Related Disease of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, Chengdu 610041, PR ChinaDepartment of Gynecology and Obstetrics, Development and Related Disease of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, Chengdu 610041, PR ChinaCorresponding author.; Department of Gynecology and Obstetrics, Development and Related Disease of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, West China Second Hospital, Sichuan University, Chengdu 610041, PR ChinaDrug resistance is the main obstacle to achieving a cure in many cancer patients. Reactive oxygen species (ROS) are master regulators of cancer development that act through complex mechanisms. Remarkably, ROS levels and antioxidant content are typically higher in drug-resistant cancer cells than in non-resistant and normal cells, and have been shown to play a central role in modulating drug resistance. Therefore, determining the underlying functions of ROS in the modulation of drug resistance will contribute to develop therapies that sensitize cancer resistant cells by leveraging ROS modulation. In this review, we summarize the notable literature on the sources and regulation of ROS production and highlight the complex roles of ROS in cancer chemoresistance, encompassing transcription factor–mediated chemoresistance, maintenance of cancer stem cells, and their impact on the tumor microenvironment. We also discuss the potential of ROS-targeted therapies in overcoming tumor therapeutic resistance.http://www.sciencedirect.com/science/article/pii/S0753332223008260ROSCellular redox balanceChemoresistanceTarget therapy
spellingShingle Xiaoting Zhou
Biao An
Yi Lin
Yanghong Ni
Xia Zhao
Xiao Liang
Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies
Biomedicine & Pharmacotherapy
ROS
Cellular redox balance
Chemoresistance
Target therapy
title Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies
title_full Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies
title_fullStr Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies
title_full_unstemmed Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies
title_short Molecular mechanisms of ROS-modulated cancer chemoresistance and therapeutic strategies
title_sort molecular mechanisms of ros modulated cancer chemoresistance and therapeutic strategies
topic ROS
Cellular redox balance
Chemoresistance
Target therapy
url http://www.sciencedirect.com/science/article/pii/S0753332223008260
work_keys_str_mv AT xiaotingzhou molecularmechanismsofrosmodulatedcancerchemoresistanceandtherapeuticstrategies
AT biaoan molecularmechanismsofrosmodulatedcancerchemoresistanceandtherapeuticstrategies
AT yilin molecularmechanismsofrosmodulatedcancerchemoresistanceandtherapeuticstrategies
AT yanghongni molecularmechanismsofrosmodulatedcancerchemoresistanceandtherapeuticstrategies
AT xiazhao molecularmechanismsofrosmodulatedcancerchemoresistanceandtherapeuticstrategies
AT xiaoliang molecularmechanismsofrosmodulatedcancerchemoresistanceandtherapeuticstrategies